Logo image of IBA

INDUSTRIAS BACHOCO SAB SP AD (IBA) Stock Fundamental Analysis

NYSE:IBA - US4564631087 - ADR

53 USD
-0.98 (-1.82%)
Last: 4/21/2023, 8:04:00 PM
57.96 USD
+4.96 (+9.36%)
After Hours: 4/21/2023, 8:04:00 PM
Fundamental Rating

7

IBA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. While IBA has a great health rating, its profitability is only average at the moment. IBA has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

IBA had positive earnings in the past year.
IBA had a positive operating cash flow in the past year.
IBA Yearly Net Income VS EBIT VS OCF VS FCFIBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

1.2 Ratios

IBA's Return On Assets of 7.74% is amongst the best of the industry. IBA outperforms 82.80% of its industry peers.
IBA has a better Return On Equity (10.30%) than 68.82% of its industry peers.
IBA's Return On Invested Capital of 8.78% is amongst the best of the industry. IBA outperforms 83.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IBA is significantly below the industry average of 29.14%.
Industry RankSector Rank
ROA 7.74%
ROE 10.3%
ROIC 8.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.29%
ROIC(5y)N/A
IBA Yearly ROA, ROE, ROICIBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

IBA's Profit Margin of 5.91% is fine compared to the rest of the industry. IBA outperforms 70.97% of its industry peers.
IBA's Profit Margin has declined in the last couple of years.
IBA has a Operating Margin of 7.47%. This is in the better half of the industry: IBA outperforms 70.97% of its industry peers.
In the last couple of years the Operating Margin of IBA has declined.
IBA has a Gross Margin of 16.44%. This is comparable to the rest of the industry: IBA outperforms 48.39% of its industry peers.
IBA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.47%
PM (TTM) 5.91%
GM 16.44%
OM growth 3Y7.93%
OM growth 5Y-3.8%
PM growth 3Y4.16%
PM growth 5Y-3.96%
GM growth 3Y1.17%
GM growth 5Y-1.97%
IBA Yearly Profit, Operating, Gross MarginsIBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 5 10 15 20

More info and screens

9

2. Health

2.1 Basic Checks

IBA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IBA has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for IBA has been reduced compared to a year ago.
IBA Yearly Shares OutstandingIBA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
IBA Yearly Total Debt VS Total AssetsIBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B

2.2 Solvency

An Altman-Z score of 4.84 indicates that IBA is not in any danger for bankruptcy at the moment.
IBA has a Altman-Z score of 4.84. This is amongst the best in the industry. IBA outperforms 84.95% of its industry peers.
IBA has a debt to FCF ratio of 0.97. This is a very positive value and a sign of high solvency as it would only need 0.97 years to pay back of all of its debts.
IBA has a Debt to FCF ratio of 0.97. This is amongst the best in the industry. IBA outperforms 93.55% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that IBA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.01, IBA belongs to the best of the industry, outperforming 84.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.97
Altman-Z 4.84
ROIC/WACC0.65
WACC13.53%
IBA Yearly LT Debt VS Equity VS FCFIBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 10B 20B 30B 40B

2.3 Liquidity

IBA has a Current Ratio of 3.36. This indicates that IBA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IBA (3.36) is better than 80.65% of its industry peers.
IBA has a Quick Ratio of 2.44. This indicates that IBA is financially healthy and has no problem in meeting its short term obligations.
IBA has a better Quick ratio (2.44) than 86.02% of its industry peers.
Industry RankSector Rank
Current Ratio 3.36
Quick Ratio 2.44
IBA Yearly Current Assets VS Current LiabilitesIBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10B 20B 30B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 714.76% over the past year.
The Earnings Per Share has been growing slightly by 5.07% on average over the past years.
Looking at the last year, IBA shows a quite strong growth in Revenue. The Revenue has grown by 19.74% in the last year.
IBA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.45% yearly.
EPS 1Y (TTM)714.76%
EPS 3Y13.96%
EPS 5Y5.07%
EPS Q2Q%1164.61%
Revenue 1Y (TTM)19.74%
Revenue growth 3Y10.2%
Revenue growth 5Y9.45%
Sales Q2Q%25.88%

3.2 Future

The Earnings Per Share is expected to grow by 8.09% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.58% on average over the next years. This is quite good.
EPS Next Y35.55%
EPS Next 2Y9.63%
EPS Next 3Y9.56%
EPS Next 5Y8.09%
Revenue Next Year24.45%
Revenue Next 2Y12.86%
Revenue Next 3Y9.99%
Revenue Next 5Y8.58%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IBA Yearly Revenue VS EstimatesIBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B
IBA Yearly EPS VS EstimatesIBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.62, the valuation of IBA can be described as very cheap.
IBA's Price/Earnings ratio is rather cheap when compared to the industry. IBA is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of IBA to the average of the S&P500 Index (26.76), we can say IBA is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.84, the valuation of IBA can be described as very cheap.
IBA's Price/Forward Earnings ratio is rather cheap when compared to the industry. IBA is cheaper than 96.77% of the companies in the same industry.
IBA is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.62
Fwd PE 7.84
IBA Price Earnings VS Forward Price EarningsIBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IBA is valued cheaply inside the industry as 91.40% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IBA is valued cheaper than 89.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.17
EV/EBITDA 3.64
IBA Per share dataIBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

IBA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.05
PEG (5Y)0.32
EPS Next 2Y9.63%
EPS Next 3Y9.56%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.93%, IBA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.55, IBA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, IBA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.93%

5.2 History

The dividend of IBA has a limited annual growth rate of 5.42%.
IBA has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of IBA decreased in the last 3 years.
Dividend Growth(5Y)5.42%
Div Incr Years2
Div Non Decr Years2
IBA Yearly Dividends per shareIBA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5

5.3 Sustainability

IBA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y9.63%
EPS Next 3Y9.56%
IBA Yearly Income VS Free CF VS DividendIBA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B 5B

More info and screens

INDUSTRIAS BACHOCO SAB SP AD

NYSE:IBA (4/21/2023, 8:04:00 PM)

After market: 57.96 +4.96 (+9.36%)

53

-0.98 (-1.82%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-27 2023-04-27/amc
Earnings (Next)07-25 2023-07-25/amc
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.65B
Analysts81.82
Price Target55.47 (4.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.93%
Yearly Dividend1.64
Dividend Growth(5Y)5.42%
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.54%
Min EPS beat(2)7.54%
Max EPS beat(2)7.54%
EPS beat(4)2
Avg EPS beat(4)7.88%
Min EPS beat(4)-2.91%
Max EPS beat(4)19.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.66%
Min Revenue beat(2)4.66%
Max Revenue beat(2)4.66%
Revenue beat(4)2
Avg Revenue beat(4)2.3%
Min Revenue beat(4)-0.19%
Max Revenue beat(4)4.66%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.97%
PT rev (3m)-9.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 1.62
Fwd PE 7.84
P/S 0.55
P/FCF 17.17
P/OCF 7.21
P/B 0.96
P/tB 1.03
EV/EBITDA 3.64
EPS(TTM)32.75
EY61.79%
EPS(NY)6.76
Fwd EY12.75%
FCF(TTM)3.09
FCFY5.83%
OCF(TTM)7.35
OCFY13.86%
SpS96.19
BVpS55.18
TBVpS51.33
PEG (NY)0.05
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 7.74%
ROE 10.3%
ROCE N/A
ROIC 8.78%
ROICexc 13.8%
ROICexgc 15.31%
OM 7.47%
PM (TTM) 5.91%
GM 16.44%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.29%
ROIC(5y)N/A
ROICexc(3y)11.31%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y8.36%
ROICexcg growth 5Y-2.29%
ROICexc growth 3Y9.51%
ROICexc growth 5Y-3.31%
OM growth 3Y7.93%
OM growth 5Y-3.8%
PM growth 3Y4.16%
PM growth 5Y-3.96%
GM growth 3Y1.17%
GM growth 5Y-1.97%
F-Score7
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.97
Debt/EBITDA 0.32
Cap/Depr 204.45%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 54.34%
Current Ratio 3.36
Quick Ratio 2.44
Altman-Z 4.84
F-Score7
WACC13.53%
ROIC/WACC0.65
Cap/Depr(3y)148.6%
Cap/Depr(5y)160.93%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)59.84%
Profit Quality(5y)58.58%
High Growth Momentum
Growth
EPS 1Y (TTM)714.76%
EPS 3Y13.96%
EPS 5Y5.07%
EPS Q2Q%1164.61%
EPS Next Y35.55%
EPS Next 2Y9.63%
EPS Next 3Y9.56%
EPS Next 5Y8.09%
Revenue 1Y (TTM)19.74%
Revenue growth 3Y10.2%
Revenue growth 5Y9.45%
Sales Q2Q%25.88%
Revenue Next Year24.45%
Revenue Next 2Y12.86%
Revenue Next 3Y9.99%
Revenue Next 5Y8.58%
EBIT growth 1Y3.49%
EBIT growth 3Y18.93%
EBIT growth 5Y5.29%
EBIT Next Year72.63%
EBIT Next 3Y17.79%
EBIT Next 5Y14.91%
FCF growth 1Y-36.2%
FCF growth 3Y24.28%
FCF growth 5Y87.05%
OCF growth 1Y2.74%
OCF growth 3Y22.3%
OCF growth 5Y17.04%